Brief: Fusion Pharmaceuticals Appoints Dmitri Bobilev As Chief Medical Officer
07/11/2022 22:40
Nov 7 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS APPOINTS DMITRI BOBILEV, M.D. AS
CHIEF
MEDICAL OFFICER
Source text for Eikon: ID:nCNWs6qtka
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary